US Stock MarketDetailed Quotes

DYN Dyne Therapeutics

Watchlist
  • 13.610
  • +0.440+3.34%
Close Feb 28 16:00 ET
  • 13.610
  • 0.0000.00%
Post 16:19 ET
1.54BMarket Cap-4.04P/E (TTM)

Dyne Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments
421.74%642.27M
421.74%642.27M
358.54%723.67M
274.92%778.84M
90.40%453.55M
-51.92%123.1M
-51.92%123.1M
-36.40%157.82M
-28.82%207.73M
-26.28%238.21M
-Cash and cash equivalents
258.02%435.45M
258.02%435.45M
308.48%532.16M
262.87%608.2M
50.20%272.04M
-29.35%121.63M
-29.35%121.63M
-10.09%130.28M
23.26%167.61M
22.40%181.11M
-Short-term investments
13,931.14%206.82M
13,931.14%206.82M
595.29%191.51M
325.28%170.64M
217.90%181.51M
-98.24%1.47M
-98.24%1.47M
-73.32%27.54M
-74.26%40.13M
-67.41%57.1M
Other current assets
171.09%17.01M
171.09%17.01M
22.35%12.72M
147.83%13.48M
214.41%34.59M
-34.51%6.28M
-34.51%6.28M
2.98%10.39M
-10.76%5.44M
-48.34%11M
Total current assets
409.59%659.28M
409.59%659.28M
337.76%736.39M
271.68%792.32M
95.87%488.14M
-51.29%129.38M
-51.29%129.38M
-34.86%168.22M
-28.45%213.17M
-27.65%249.21M
Non current assets
Net PPE
-10.12%30.01M
-10.12%30.01M
-12.06%30.52M
-11.94%31.64M
-13.18%32.22M
-13.07%33.39M
-13.07%33.39M
-11.31%34.7M
-9.68%35.93M
-9.49%37.11M
-Gross PPE
-4.90%36.79M
-4.90%36.79M
-6.48%37.03M
-6.62%37.71M
-7.89%37.89M
-7.99%38.68M
-7.99%38.68M
-6.60%39.59M
-5.30%40.38M
-5.24%41.13M
-Accumulated depreciation
-28.08%-6.77M
-28.08%-6.77M
-33.13%-6.51M
-36.20%-6.07M
-40.85%-5.67M
-45.72%-5.29M
-45.72%-5.29M
-49.77%-4.89M
-55.44%-4.46M
-67.23%-4.03M
Other non current assets
-16.11%1.94M
-16.11%1.94M
-16.69%1.94M
-17.05%1.93M
-17.28%1.92M
-0.17%2.32M
-0.17%2.32M
0.35%2.33M
0.35%2.32M
0.35%2.32M
Total non current assets
-10.51%31.96M
-10.51%31.96M
-12.35%32.45M
-12.25%33.56M
-13.42%34.14M
-12.33%35.71M
-12.33%35.71M
-10.66%37.03M
-9.13%38.25M
-8.97%39.43M
Total assets
318.72%691.23M
318.72%691.23M
274.60%768.84M
228.49%825.88M
80.94%522.28M
-46.11%165.08M
-46.11%165.08M
-31.51%205.24M
-26.06%251.42M
-25.56%288.64M
Liabilities
Current liabilities
Payables
-71.39%6.56M
-71.39%6.56M
73.29%6.16M
-30.65%1.89M
-17.74%7.21M
336.13%22.94M
336.13%22.94M
286.62%3.55M
-60.93%2.72M
69.04%8.77M
-accounts payable
-71.39%6.56M
-71.39%6.56M
73.29%6.16M
-30.65%1.89M
-17.74%7.21M
336.13%22.94M
336.13%22.94M
286.62%3.55M
-60.93%2.72M
69.04%8.77M
Current accrued expenses
31.60%30.85M
31.60%30.85M
50.70%32.29M
80.58%23.09M
27.16%10.39M
28.65%23.44M
28.65%23.44M
20.20%21.43M
-2.86%12.78M
-38.72%8.17M
Current debt and capital lease obligation
2.75%4.85M
2.75%4.85M
2.14%4.81M
1.40%4.78M
2.41%4.76M
2.39%4.72M
2.39%4.72M
2.99%4.71M
-14.14%4.71M
-1.42%4.64M
-Current capital lease obligation
2.75%4.85M
2.75%4.85M
2.14%4.81M
1.40%4.78M
2.41%4.76M
2.39%4.72M
2.39%4.72M
2.99%4.71M
-14.14%4.71M
-1.42%4.64M
Current liabilities
-17.30%42.26M
-17.30%42.26M
45.70%43.26M
47.14%29.75M
3.59%22.36M
81.91%51.1M
81.91%51.1M
27.32%29.69M
-21.08%20.22M
-7.10%21.59M
Non current liabilities
Long term debt and capital lease obligation
-15.67%19.14M
-15.67%19.14M
-14.76%20.04M
-13.92%20.94M
-12.97%21.86M
-12.28%22.7M
-12.28%22.7M
-11.65%23.51M
-11.05%24.32M
-10.50%25.12M
-Long term capital lease obligation
-15.67%19.14M
-15.67%19.14M
-14.76%20.04M
-13.92%20.94M
-12.97%21.86M
-12.28%22.7M
-12.28%22.7M
-11.65%23.51M
-11.05%24.32M
-10.50%25.12M
Total non current liabilities
-15.67%19.14M
-15.67%19.14M
-14.76%20.04M
-13.92%20.94M
-12.97%21.86M
-12.28%22.7M
-12.28%22.7M
-11.65%23.51M
-11.05%24.32M
-10.50%25.12M
Total liabilities
-16.80%61.4M
-16.80%61.4M
18.98%63.3M
13.80%50.69M
-5.32%44.22M
36.75%73.79M
36.75%73.79M
6.55%53.21M
-15.90%44.54M
-8.96%46.71M
Shareholders'equity
Share capital
66.67%10K
66.67%10K
66.67%10K
66.67%10K
50.00%9K
0.00%6K
0.00%6K
0.00%6K
0.00%6K
0.00%6K
-common stock
66.67%10K
66.67%10K
66.67%10K
66.67%10K
50.00%9K
0.00%6K
0.00%6K
0.00%6K
0.00%6K
0.00%6K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-50.18%-949.93M
-50.18%-949.93M
-52.05%-860.39M
-50.94%-763.26M
-58.40%-698.16M
-59.49%-632.51M
-59.49%-632.51M
-58.18%-565.87M
-59.84%-505.66M
-66.92%-440.76M
Paid-in capital
118.26%1.58B
118.26%1.58B
118.05%1.57B
115.93%1.54B
72.26%1.18B
11.44%723.8M
11.44%723.8M
17.99%717.92M
17.87%712.59M
13.54%682.89M
Gains losses not affecting retained earnings
--6K
--6K
3,776.92%478K
-328.57%-240K
34.98%-132K
--0
--0
98.68%-13K
95.16%-56K
78.17%-203K
Total stockholders'equity
589.92%629.84M
589.92%629.84M
364.06%705.54M
274.71%775.19M
97.60%478.06M
-63.83%91.29M
-63.83%91.29M
-39.12%152.04M
-27.93%206.88M
-28.09%241.94M
Total equity
589.92%629.84M
589.92%629.84M
364.06%705.54M
274.71%775.19M
97.60%478.06M
-63.83%91.29M
-63.83%91.29M
-39.12%152.04M
-27.93%206.88M
-28.09%241.94M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments 421.74%642.27M421.74%642.27M358.54%723.67M274.92%778.84M90.40%453.55M-51.92%123.1M-51.92%123.1M-36.40%157.82M-28.82%207.73M-26.28%238.21M
-Cash and cash equivalents 258.02%435.45M258.02%435.45M308.48%532.16M262.87%608.2M50.20%272.04M-29.35%121.63M-29.35%121.63M-10.09%130.28M23.26%167.61M22.40%181.11M
-Short-term investments 13,931.14%206.82M13,931.14%206.82M595.29%191.51M325.28%170.64M217.90%181.51M-98.24%1.47M-98.24%1.47M-73.32%27.54M-74.26%40.13M-67.41%57.1M
Other current assets 171.09%17.01M171.09%17.01M22.35%12.72M147.83%13.48M214.41%34.59M-34.51%6.28M-34.51%6.28M2.98%10.39M-10.76%5.44M-48.34%11M
Total current assets 409.59%659.28M409.59%659.28M337.76%736.39M271.68%792.32M95.87%488.14M-51.29%129.38M-51.29%129.38M-34.86%168.22M-28.45%213.17M-27.65%249.21M
Non current assets
Net PPE -10.12%30.01M-10.12%30.01M-12.06%30.52M-11.94%31.64M-13.18%32.22M-13.07%33.39M-13.07%33.39M-11.31%34.7M-9.68%35.93M-9.49%37.11M
-Gross PPE -4.90%36.79M-4.90%36.79M-6.48%37.03M-6.62%37.71M-7.89%37.89M-7.99%38.68M-7.99%38.68M-6.60%39.59M-5.30%40.38M-5.24%41.13M
-Accumulated depreciation -28.08%-6.77M-28.08%-6.77M-33.13%-6.51M-36.20%-6.07M-40.85%-5.67M-45.72%-5.29M-45.72%-5.29M-49.77%-4.89M-55.44%-4.46M-67.23%-4.03M
Other non current assets -16.11%1.94M-16.11%1.94M-16.69%1.94M-17.05%1.93M-17.28%1.92M-0.17%2.32M-0.17%2.32M0.35%2.33M0.35%2.32M0.35%2.32M
Total non current assets -10.51%31.96M-10.51%31.96M-12.35%32.45M-12.25%33.56M-13.42%34.14M-12.33%35.71M-12.33%35.71M-10.66%37.03M-9.13%38.25M-8.97%39.43M
Total assets 318.72%691.23M318.72%691.23M274.60%768.84M228.49%825.88M80.94%522.28M-46.11%165.08M-46.11%165.08M-31.51%205.24M-26.06%251.42M-25.56%288.64M
Liabilities
Current liabilities
Payables -71.39%6.56M-71.39%6.56M73.29%6.16M-30.65%1.89M-17.74%7.21M336.13%22.94M336.13%22.94M286.62%3.55M-60.93%2.72M69.04%8.77M
-accounts payable -71.39%6.56M-71.39%6.56M73.29%6.16M-30.65%1.89M-17.74%7.21M336.13%22.94M336.13%22.94M286.62%3.55M-60.93%2.72M69.04%8.77M
Current accrued expenses 31.60%30.85M31.60%30.85M50.70%32.29M80.58%23.09M27.16%10.39M28.65%23.44M28.65%23.44M20.20%21.43M-2.86%12.78M-38.72%8.17M
Current debt and capital lease obligation 2.75%4.85M2.75%4.85M2.14%4.81M1.40%4.78M2.41%4.76M2.39%4.72M2.39%4.72M2.99%4.71M-14.14%4.71M-1.42%4.64M
-Current capital lease obligation 2.75%4.85M2.75%4.85M2.14%4.81M1.40%4.78M2.41%4.76M2.39%4.72M2.39%4.72M2.99%4.71M-14.14%4.71M-1.42%4.64M
Current liabilities -17.30%42.26M-17.30%42.26M45.70%43.26M47.14%29.75M3.59%22.36M81.91%51.1M81.91%51.1M27.32%29.69M-21.08%20.22M-7.10%21.59M
Non current liabilities
Long term debt and capital lease obligation -15.67%19.14M-15.67%19.14M-14.76%20.04M-13.92%20.94M-12.97%21.86M-12.28%22.7M-12.28%22.7M-11.65%23.51M-11.05%24.32M-10.50%25.12M
-Long term capital lease obligation -15.67%19.14M-15.67%19.14M-14.76%20.04M-13.92%20.94M-12.97%21.86M-12.28%22.7M-12.28%22.7M-11.65%23.51M-11.05%24.32M-10.50%25.12M
Total non current liabilities -15.67%19.14M-15.67%19.14M-14.76%20.04M-13.92%20.94M-12.97%21.86M-12.28%22.7M-12.28%22.7M-11.65%23.51M-11.05%24.32M-10.50%25.12M
Total liabilities -16.80%61.4M-16.80%61.4M18.98%63.3M13.80%50.69M-5.32%44.22M36.75%73.79M36.75%73.79M6.55%53.21M-15.90%44.54M-8.96%46.71M
Shareholders'equity
Share capital 66.67%10K66.67%10K66.67%10K66.67%10K50.00%9K0.00%6K0.00%6K0.00%6K0.00%6K0.00%6K
-common stock 66.67%10K66.67%10K66.67%10K66.67%10K50.00%9K0.00%6K0.00%6K0.00%6K0.00%6K0.00%6K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -50.18%-949.93M-50.18%-949.93M-52.05%-860.39M-50.94%-763.26M-58.40%-698.16M-59.49%-632.51M-59.49%-632.51M-58.18%-565.87M-59.84%-505.66M-66.92%-440.76M
Paid-in capital 118.26%1.58B118.26%1.58B118.05%1.57B115.93%1.54B72.26%1.18B11.44%723.8M11.44%723.8M17.99%717.92M17.87%712.59M13.54%682.89M
Gains losses not affecting retained earnings --6K--6K3,776.92%478K-328.57%-240K34.98%-132K--0--098.68%-13K95.16%-56K78.17%-203K
Total stockholders'equity 589.92%629.84M589.92%629.84M364.06%705.54M274.71%775.19M97.60%478.06M-63.83%91.29M-63.83%91.29M-39.12%152.04M-27.93%206.88M-28.09%241.94M
Total equity 589.92%629.84M589.92%629.84M364.06%705.54M274.71%775.19M97.60%478.06M-63.83%91.29M-63.83%91.29M-39.12%152.04M-27.93%206.88M-28.09%241.94M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------
Trending Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
Cars.com
CARS
+9.73%
Lantheus
LNTH
+2.55%
Halozyme Therapeutics
HALO
+2.51%
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
+2.27%
Collegium Pharmaceutical
COLL
+2.22%

Unlock the Full List